Healthcare provider profile · identity verified

Luis Vega, M.D.

Family Practice · COLON, MI · NPI 1659398592

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	250	67
Lisinopril	Lisinopril	247	73
Atorvastatin Calcium	Atorvastatin Calcium	228	73
Omeprazole	Omeprazole	181	57
Metformin Hcl	Metformin Hcl	180	61
Losartan Potassium	Losartan Potassium	175	52
Levothyroxine Sodium	Levothyroxine Sodium	173	48
Pantoprazole Sodium	Pantoprazole Sodium	157	41
Carvedilol	Carvedilol	133	31
Gabapentin	Gabapentin	130	38
Metoprolol Succinate	Metoprolol Succinate	128	40
Tamsulosin Hcl	Tamsulosin Hcl	113	37
Simvastatin	Simvastatin	107	35
Tramadol Hcl	Tramadol Hcl	100	30
Ozempic	Semaglutide	91	16
Hydrochlorothiazide	Hydrochlorothiazide	85	29
Clopidogrel	Clopidogrel Bisulfate	81	26
Albuterol Sulfate Hfa	Albuterol Sulfate	78	33
Fluticasone Propionate	Fluticasone Propionate	77	34
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	77	26
Furosemide	Furosemide	76	33
Meloxicam	Meloxicam	76	31
Metoprolol Tartrate	Metoprolol Tartrate	76	25
Sertraline Hcl	Sertraline Hcl	75	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	20
Rosuvastatin Calcium	Rosuvastatin Calcium	69	21
Trulicity	Dulaglutide	68	13
Potassium Chloride	Potassium Chloride	64	26
Alendronate Sodium	Alendronate Sodium	59	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	16
Escitalopram Oxalate	Escitalopram Oxalate	56	15
Pravastatin Sodium	Pravastatin Sodium	56	13
Glipizide	Glipizide	54	18
Glipizide Er	Glipizide	53	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	suppressed
Clonidine Hcl	Clonidine Hcl	52	17
Buspirone Hcl	Buspirone Hcl	50	15
Tizanidine Hcl	Tizanidine Hcl	49	15
Prednisone	Prednisone	47	38
Trazodone Hcl	Trazodone Hcl	47	19
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	46	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	suppressed
Azithromycin	Azithromycin	43	36
Alprazolam	Alprazolam	38	13
Xarelto	Rivaroxaban	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	11
Diclofenac Sodium	Diclofenac Sodium	35	15
Enalapril Maleate	Enalapril Maleate	35	suppressed
Spironolactone	Spironolactone	33	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	11
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Jardiance	Empagliflozin	30	12
Meclizine Hcl	Meclizine Hcl	30	11
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Cephalexin	Cephalexin	28	23
Atenolol	Atenolol	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Finasteride	Finasteride	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Mometasone Furoate	Mometasone Furoate	26	18
Ropinirole Hcl	Ropinirole Hcl	25	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Bumetanide	Bumetanide	23	suppressed
Fluconazole	Fluconazole	22	16
Mupirocin	Mupirocin	22	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	14
Eliquis	Apixaban	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Famotidine	Famotidine	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Primidone	Primidone	18	suppressed
Naproxen	Naproxen	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	11
Cefadroxil	Cefadroxil	12	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Terconazole	Terconazole	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error